DIETARY CAROTENOIDS - LIPOPROTEIN/CELL INTERACTIONS
膳食类胡萝卜素 - 脂蛋白/细胞相互作用
基本信息
- 批准号:6692153
- 负责人:
- 金额:$ 20万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-07-01 至 2005-12-31
- 项目状态:已结题
- 来源:
- 关键词:antioxidantsatherosclerosisblood lipoproteincarotenoidscell linecholesterolchylomicronsclinical researchdietary constituentgastrointestinal absorption /transportgene expressionhuman subjectintestineslipid transportmacrophagemonocytenutrient bioavailabilitynutrition related tagphenotyperetinoidsstable isotopesterolstissue /cell culturevitamin metabolism
项目摘要
Humans obtain carotenoids in the diet from fruits and vegetables. The role of carotenoids as antioxidants has been the focus of our work on lipoprotein oxidation. While it is clear that lipoproteins are the main vehicles for transport of carotenoids, little is known about mechanisms of intestinal absorption of carotenoids. We now seek to define the mechanism(s) of intestinal absorption of carotenoids and their distribution into blood cells. We focus on the interaction of carotenoids and the human monocyte/macrophage since this interaction may play a role in the development of atherosclerosis. Specific aims are: 1. Mechanisms of intestinal absorption of carotenoids and their incorporation into chylomicrons in CACO-2 cells in culture. We will test the hypothesis that other fat-soluble nutrients inhibit the incorporation of beta-carotene into chylomicrons. We will test the hypothesis that SRB1, CD-36, FAT, and other putative lipid transporters mediate the uptake of beta-carotene into the cell. We will test the hypothesis the increasing the expression of beta-carotene 15,15' dioxygenase increases the total flux of beta-carotene through the cell. 2. Intestinal absorption of beta-carotene in humans. We will use stable isotope methodology to study the mechanisms of the intestinal absorption of beta- carotene in humans. The general question under investigation is whether there are common mechanisms for the absorption of various fat-soluble dietary nutrients. We will test the hypothesis that the efficiency of intestinal absorption of cholesterol is positively correlated with the efficiency of the intestinal absorption of beta-carotene. We will test the hypothesis that beta-carotene is converted to vitamin A solely in the intestine. We will quantify the conversion of beta-carotene to vitamin A to test the hypothesis that increased absorption of beta-carotene is associated with increased conversion to vitamin A. 3. Modulation of macrophage function by dietary carotenoids. We will use the U937 cell line as well as human peripheral blood monocyte- macrophages to examine the partitioning of carotenoids into blood-borne cells and the effects of carotenoid enrichment on monocyte-macrophage function. We will test the hypothesis that plasma carotenoids partition into various blood cells as well as into plasma lipoproteins. We will test the hypothesis that carotenoid enrichment alters monocyte-macrophage phenotype, either enhancing or inhibiting potentially pro-atherosclerotic aspects of cell function including response to chemotactic stimuli, adhesion to endothelial cells, differentiation into macrophages, ability to oxidize LDL, and ability to form foam cells.
人类从水果和蔬菜中获取类胡萝卜素。类胡萝卜素作为抗氧化剂的作用一直是我们在脂蛋白氧化方面工作的重点。虽然很明显,脂蛋白是类胡萝卜素运输的主要载体,但对肠道吸收类胡萝卜素的机制知之甚少。我们现在试图确定肠道吸收类胡萝卜素及其在血细胞中的分布机制。我们关注类胡萝卜素与人类单核细胞/巨噬细胞的相互作用,因为这种相互作用可能在动脉粥样硬化的发展中发挥作用。具体目标是:1.;培养CACO-2细胞肠道吸收类胡萝卜素及其进入乳糜微粒的机制。我们将测试其他脂溶性营养素抑制β -胡萝卜素进入乳糜微粒的假设。我们将验证SRB1、CD-36、FAT和其他假定的脂质转运体介导β -胡萝卜素进入细胞的摄取的假设。我们将检验β -胡萝卜素15,15'双加氧酶表达的增加会增加β -胡萝卜素通过细胞的总通量的假设。2. -胡萝卜素在人体中的肠道吸收。我们将使用稳定同位素方法来研究人类肠道吸收β -胡萝卜素的机制。正在研究的一般问题是,是否存在吸收各种脂溶性膳食营养素的共同机制。我们将检验肠道吸收胆固醇的效率与肠道吸收β -胡萝卜素的效率正相关的假设。我们将测试β -胡萝卜素仅在肠道内转化为维生素A的假设。我们将量化β -胡萝卜素转化为维生素A的过程,以检验β -胡萝卜素吸收增加与维生素A转化增加有关的假设。膳食类胡萝卜素对巨噬细胞功能的调节。我们将使用U937细胞系以及人外周血单核-巨噬细胞来检测类胡萝卜素在血源性细胞中的分配以及类胡萝卜素富集对单核-巨噬细胞功能的影响。我们将测试血浆类胡萝卜素分裂成各种血细胞以及血浆脂蛋白的假设。我们将测试类胡萝卜素富集改变单核巨噬细胞表型的假设,增强或抑制细胞功能的潜在促动脉粥样硬化方面,包括对趋化刺激的反应、与内皮细胞的粘附、向巨噬细胞的分化、氧化LDL的能力和形成泡沫细胞的能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EARL Howard HARRISON其他文献
EARL Howard HARRISON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EARL Howard HARRISON', 18)}}的其他基金
DIETARY CAROTENOIDS--TRANSPORT IN HUMAN PLASMA
膳食类胡萝卜素——在人体血浆中的运输
- 批准号:
2225914 - 财政年份:1994
- 资助金额:
$ 20万 - 项目类别:
DIETARY CAROTENOIDS--TRANSPORT IN HUMAN PLASMA
膳食类胡萝卜素——在人体血浆中的运输
- 批准号:
2225916 - 财政年份:1994
- 资助金额:
$ 20万 - 项目类别:
DIETARY CAROTENOIDS - LIPOPROTEIN/CELL INTERACTIONS
膳食类胡萝卜素 - 脂蛋白/细胞相互作用
- 批准号:
6621641 - 财政年份:1994
- 资助金额:
$ 20万 - 项目类别:
Cleavage Products of Dietary Carotenoids: Occurrence & Nutritional Function
膳食类胡萝卜素的裂解产物:发生情况
- 批准号:
8403982 - 财政年份:1994
- 资助金额:
$ 20万 - 项目类别:
DIETARY CAROTENOIDS - LIPOPROTEIN/CELL INTERACTIONS
膳食类胡萝卜素 - 脂蛋白/细胞相互作用
- 批准号:
6435490 - 财政年份:1994
- 资助金额:
$ 20万 - 项目类别:
DIETARY CAROTENOIDS--LIPOPROTEIN CELL INTERACTIONS
膳食类胡萝卜素--脂蛋白细胞相互作用
- 批准号:
2605540 - 财政年份:1994
- 资助金额:
$ 20万 - 项目类别:
DIETARY CAROTENOIDS--LIPOPROTEIN CELL INTERACTIONS
膳食类胡萝卜素--脂蛋白细胞相互作用
- 批准号:
6043797 - 财政年份:1994
- 资助金额:
$ 20万 - 项目类别:
Cleavage Products of Dietary Carotenoids: Occurrence & Nutritional Function
膳食类胡萝卜素的裂解产物:发生情况
- 批准号:
8208203 - 财政年份:1994
- 资助金额:
$ 20万 - 项目类别:
Cleavage Products of Dietary Carotenoids: Occurrence & Nutritional Function
膳食类胡萝卜素的裂解产物:发生情况
- 批准号:
8018594 - 财政年份:1994
- 资助金额:
$ 20万 - 项目类别:
相似国自然基金
卡路里限制的T细胞糖脂代谢重塑机制及网络调控
- 批准号:91957111
- 批准年份:2019
- 资助金额:80.0 万元
- 项目类别:重大研究计划
高尿酸血症促进动脉粥样硬化机制探讨
- 批准号:81170251
- 批准年份:2011
- 资助金额:14.0 万元
- 项目类别:面上项目
磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
- 批准号:81070247
- 批准年份:2010
- 资助金额:33.0 万元
- 项目类别:面上项目
大麻素CB2受体:巨噬细胞efferocytosis功能调控和不稳定斑块防治的新靶点
- 批准号:81000086
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
抑制PI3K/Akt/mTOR/p70S6K 信号通路促进巨噬细胞自体吞噬稳定易损斑块的分子机制研究
- 批准号:30971216
- 批准年份:2009
- 资助金额:31.0 万元
- 项目类别:面上项目
基因缺失突变抑制白细胞趋化稳定动脉粥样硬化易损斑块的研究
- 批准号:30871040
- 批准年份:2008
- 资助金额:32.0 万元
- 项目类别:面上项目
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Contribution of Endothelial Planar Cell Polarity pathways in Blood Flow Direction Sensing
内皮平面细胞极性通路在血流方向传感中的贡献
- 批准号:
10750690 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Colchicine for the prevention of vascular events after an acute intracerebral hemorrhage (CoVasc-ICH)
秋水仙碱用于预防急性脑出血后血管事件(CoVasc-ICH)
- 批准号:
485530 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Operating Grants
Identifying the Role of Sex Hormones in Carotid Atherosclerotic Plaque Instability
确定性激素在颈动脉粥样硬化斑块不稳定中的作用
- 批准号:
494557 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Operating Grants
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Studentship
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
- 批准号:
10652788 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Whole genome sequence interpretation for lipids to discover new genes and mechanisms for coronary artery disease
脂质的全基因组序列解释,以发现冠状动脉疾病的新基因和机制
- 批准号:
10722515 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:














{{item.name}}会员




